Browsing by Author Reverter Calatayud, Juan Carlos

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)
1-Mar-2016Alteración de los factores de hipercoagulabilidad en pacientes con enfermedad de Chagas crónica: ¿Pueden ser considerados marcadores de respuesta terapéutica?Pinazo, Maria-Jesus
2016Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic. ResponsePinazo, Maria-Jesus; Posada, Elizabeth; Izquierdo Lázaro, Luis; Tàssies Penella, María Dolores; Ferreira Marques, Alexandre; Lazzari, Elisa de; Aldasoro, Edelweiss; Muñoz, José; Abras Feliu, Alba; Tebar, Silvia; Gállego Culleré, M. (Montserrat); Almeida, Igor Correia de; Reverter Calatayud, Juan Carlos; Gascón i Brustenga, Joaquim
1994Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activityCervera i Segura, Ricard, 1960-; Navarro López, Margarita; López-Soto, Alfonso; Cid Xutglà, M. Cinta; Font Franco, Josep, 1953-2006; Esparza Sánchez, Jordi; Reverter Calatayud, Juan Carlos; Monteagudo Terres, Juan; Ingelmo Morín, Miguel; Urbano Márquez, A. (Álvaro)
12-Dec-2003Anticuerpos antiprotrombina y resistencia adquirida a la proteína C activada en el síndrome antifosfolipídicoMuñoz Rodríguez, Francisco José
29-Dec-2019Congenital antithrombin deficiency in patients with splanchnic vein thrombosisBaiges Aznar, Anna; Morena-Barrio, María Eugenia de la; Turon, Fanny; Miñano, Antonia; Ferrusquía, José Alberto; Magaz, Marta; Reverter Calatayud, Juan Carlos; Vicente, Vicente; Hernández Gea, Virginia; Corral, Javier; García Pagán, Juan Carlos
2000Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanismSalas Martínez, Azucena; Sans i Cuffí, Miquel; Soriano Viladomiu, Alex; Reverter Calatayud, Juan Carlos; Anderson, D. C.; Piqué, J. M. (Piqué Badía); Panés Díaz, Julià
1998Hepatitis G virus infection in primary Sjögren's syndrome: analysis in a series of 100 patients.Font Franco, Josep, 1953-2006; Tàssies Penella, María Dolores; García Carrasco, Mario; Ramos Casals, Manuel; Cervera i Segura, Ricard, 1960-; Reverter Calatayud, Juan Carlos; Sánchez Tapias, José M. (José María); Mazzara Aguirrezabal, Roberto; Ingelmo Morín, Miguel
14-Sep-2012Malaltia tromboembòlica venosa en el pacient oncològic: noves formes de presentació clínica i paper dels anticossos antifosfolípid en la seva patogèniaFont i Puig, Carme
11-Nov-2013Reversal of apixaban induced alterations in hemostasis by different coagulation factor concentrates: significance of studies in vitro with circulating human bloodEscolar Albaladejo, Ginés; Fernández Gallego, Victor; Arellano Rodrigo, Eduardo; Roquer, Jaume; Reverter Calatayud, Juan Carlos; Sanz, Victoria Veronica; Molina, Patricia; López Vilchez, Irene; Diaz Ricart, M. Isabel; Galán, Ana Maria
23-Jan-2015Reversal of rivaroxaban-induced alterations on hemostasis by different coagulation factor concentrates - In vitro studies with steady and circulating human blood -Escolar Albaladejo, Ginés; Arellano Rodrigo, Eduardo; López Vilchez, Irene; Molina, Patricia; Sanchis Forés, Juan; Reverter Calatayud, Juan Carlos; Carné Cladellas, Xavier; Cid Vidal, Joan; Villalta i Blanch, Jaume; Tàssies Penella, María Dolores; Galan, Ana M.; Diaz Ricart, M. Isabel
12-Mar-2013Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activityRecarte Pelz, Pedro; Tàssies Penella, María Dolores; Espinosa Garriga, Gerard; Hurtado, Begoña; Sala Serra, Núria; Cervera i Segura, Ricard, 1960-; Reverter Calatayud, Juan Carlos; García de Frutos, Pablo